Tracklet and Signature Representation for Multi-shot Person Re-Identification.

International audienceVideo surveillance has become more and more important in many domains for their security andsafety. Person Re-Identification (Re-ID) is one of the most interesting subjects in this area. The Re-ID systemis divided into two main stages: i) extracting feature representations to construct a person’s appearance sig-nature and ii) establishing the correspondence/matching by learning similarity metrics or ranking functions.However, appearance based person Re-ID is a challenging task due to similarity of human’s appearance andvisual ambiguities across different cameras. This paper provides a representation of the appearance descriptors,called signatures, for multi-shot Re-ID. First, we will present the tracklets, i.e trajectories of persons. Then,we compute the signature and represent it based on the approach of Part Appearance Mixture (PAM). Anevaluation of the quality of this signature representation is also described in order to essentially solve the problemsof high variance in a person’s appearance, occlusions, illumination changes and person’s orientation/pose. Todeal with variance in a person’s appearance, we represent it as a set of multi-modal feature distributions modeledby Gaussian Mixture Model (GMM). Experiments and results on two public datasets and on our own datasetshow good performance

A review of cyber-ranges and test-beds:current and future trends

Cyber situational awareness has been proven to be of value in forming a comprehensive understanding of threats and vulnerabilities within organisations, as the degree of exposure is governed by the prevailing levels of cyber-hygiene and established processes. A more accurate assessment of the security provision informs on the most vulnerable environments that necessitate more diligent management. The rapid proliferation in the automation of cyber-attacks is reducing the gap between information and operational technologies and the need to review the current levels of robustness against new sophisticated cyber-attacks, trends, technologies and mitigation countermeasures has become pressing. A deeper characterisation is also the basis with which to predict future vulnerabilities in turn guiding the most appropriate deployment technologies. Thus, refreshing established practices and the scope of the training to support the decision making of users and operators. The foundation of the training provision is the use of Cyber-Ranges (CRs) and Test-Beds (TBs), platforms/tools that help inculcate a deeper understanding of the evolution of an attack and the methodology to deploy the most impactful countermeasures to arrest breaches. In this paper, an evaluation of documented CR and TB platforms is evaluated. CRs and TBs are segmented by type, technology, threat scenarios, applications and the scope of attainable training. To enrich the analysis of documented CR and TB research and cap the study, a taxonomy is developed to provide a broader comprehension of the future of CRs and TBs. The taxonomy elaborates on the CRs/TBs dimensions, as well as, highlighting a diminishing differentiation between application areas

Cyber-security challenges in aviation industry : a review of current and future trends

The integration of Information and Communication Technology (ICT) tools into mechanical devices in routine use within the aviation industry has heightened cyber-security concerns. The extent of the inherent vulnerabilities in the software tools that drive these systems escalates as the level of integration increases. Moreover, these concerns are becoming even more acute as the migration within the industry in the deployment of electronic-enabled aircraft and smart airports gathers pace. A review of cyber-security attacks and attack surfaces within the aviation sector over the last 20 years provides a mapping of the trends and insights that are of value in informing on future frameworks to protect the evolution of a key industry. The goal is to identify common threat actors, their motivations, attacks types and map the vulnerabilities within aviation infrastructures most commonly subject to persistent attack campaigns. The analyses will enable an improved understanding of both the current and potential future cyber-security protection provisions for the sector. Evidence is provided that the main threats to the industry arise from Advance Persistent Threat (APT) groups that operate, in collaboration with a particular state actor, to steal intellectual property and intelligence in order to advance their domestic aerospace capabilities as well as monitor, infiltrate and subvert other sovereign nations’ capabilities. A segment of the aviation industry commonly attacked is the Information Technology (IT) infrastructure, the most prominent type of attack being malicious hacking with intent to gain unauthorised access. The analysis of the range of attack surfaces and the existing threat dynamics has been used as a foundation to predict future cyber-attack trends. The insights arising from the review will support the future definition and implementation of proactive measures that protect critical infrastructures against cyber-incidents that damage the confidence of customers in a key service-oriented industry

Cyber Security Certification Programmes

Although a large and fast-growing workforce for qualified cybersecurity professionals exists, developing a cybersecurity certification framework has to overcome many challenges. Towards this end, an extended review of the cybersecurity certifications offered currently on the market from 9 major issuing companies is conducted. Moreover, the guidelines for the definition of a cybersecurity certification framework as they are provided from the recent Cyber Security Act and framework of ENISA, NIST and ISO/IEC 17024 are covered. A vast comparison among the presented cybersecurity certifications is given, based not only on the cybersecurity domain covered but also the required level of candidate's experience. A proposed certification program has been also analyzed based on the learning pathways and the knowledge areas described in FORESIGHT

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Importance: Evidence regarding corticosteroid use for severe coronavirus disease 2019 (COVID-19) is limited. Objective: To determine whether hydrocortisone improves outcome for patients with severe COVID-19. Design, Setting, and Participants: An ongoing adaptive platform trial testing multiple interventions within multiple therapeutic domains, for example, antiviral agents, corticosteroids, or immunoglobulin. Between March 9 and June 17, 2020, 614 adult patients with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascular organ support at 121 sites in 8 countries. Of these, 403 were randomized to open-label interventions within the corticosteroid domain. The domain was halted after results from another trial were released. Follow-up ended August 12, 2020. Interventions: The corticosteroid domain randomized participants to a fixed 7-day course of intravenous hydrocortisone (50 mg or 100 mg every 6 hours) (n = 143), a shock-dependent course (50 mg every 6 hours when shock was clinically evident) (n = 152), or no hydrocortisone (n = 108). Main Outcomes and Measures: The primary end point was organ support-free days (days alive and free of ICU-based respiratory or cardiovascular support) within 21 days, where patients who died were assigned -1 day. The primary analysis was a bayesian cumulative logistic model that included all patients enrolled with severe COVID-19, adjusting for age, sex, site, region, time, assignment to interventions within other domains, and domain and intervention eligibility. Superiority was defined as the posterior probability of an odds ratio greater than 1 (threshold for trial conclusion of superiority >99%). Results: After excluding 19 participants who withdrew consent, there were 384 patients (mean age, 60 years; 29% female) randomized to the fixed-dose (n = 137), shock-dependent (n = 146), and no (n = 101) hydrocortisone groups; 379 (99%) completed the study and were included in the analysis. The mean age for the 3 groups ranged between 59.5 and 60.4 years; most patients were male (range, 70.6%-71.5%); mean body mass index ranged between 29.7 and 30.9; and patients receiving mechanical ventilation ranged between 50.0% and 63.5%. For the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively, the median organ support-free days were 0 (IQR, -1 to 15), 0 (IQR, -1 to 13), and 0 (-1 to 11) days (composed of 30%, 26%, and 33% mortality rates and 11.5, 9.5, and 6 median organ support-free days among survivors). The median adjusted odds ratio and bayesian probability of superiority were 1.43 (95% credible interval, 0.91-2.27) and 93% for fixed-dose hydrocortisone, respectively, and were 1.22 (95% credible interval, 0.76-1.94) and 80% for shock-dependent hydrocortisone compared with no hydrocortisone. Serious adverse events were reported in 4 (3%), 5 (3%), and 1 (1%) patients in the fixed-dose, shock-dependent, and no hydrocortisone groups, respectively. Conclusions and Relevance: Among patients with severe COVID-19, treatment with a 7-day fixed-dose course of hydrocortisone or shock-dependent dosing of hydrocortisone, compared with no hydrocortisone, resulted in 93% and 80% probabilities of superiority with regard to the odds of improvement in organ support-free days within 21 days. However, the trial was stopped early and no treatment strategy met prespecified criteria for statistical superiority, precluding definitive conclusions. Trial Registration: ClinicalTrials.gov Identifier: NCT02735707

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

Cyber Security in the Maritime Industry: A Systematic Survey of Recent Advances and Future Trends

The paper presents a classification of cyber attacks within the context of the state of the art in the maritime industry. A systematic categorization of vessel components has been conducted, complemented by an analysis of key services delivered within ports. The vulnerabilities of the Global Navigation Satellite System (GNSS) have been given particular consideration since it is a critical subcategory of many maritime infrastructures and, consequently, a target for cyber attacks. Recent research confirms that the dramatic proliferation of cyber crimes is fueled by increased levels of integration of new enabling technologies, such as IoT and Big Data. The trend to greater systems integration is, however, compelling, yielding significant business value by facilitating the operation of autonomous vessels, greater exploitation of smart ports, a reduction in the level of manpower and a marked improvement in fuel consumption and efficiency of services. Finally, practical challenges and future research trends have been highlighted

Tracklet and Signature Representation for Multi-shot Person Re-Identification.

International audienceVideo surveillance has become more and more important in many domains for their security andsafety. Person Re-Identification (Re-ID) is one of the most interesting subjects in this area. The Re-ID systemis divided into two main stages: i) extracting feature representations to construct a person’s appearance sig-nature and ii) establishing the correspondence/matching by learning similarity metrics or ranking functions.However, appearance based person Re-ID is a challenging task due to similarity of human’s appearance andvisual ambiguities across different cameras. This paper provides a representation of the appearance descriptors,called signatures, for multi-shot Re-ID. First, we will present the tracklets, i.e trajectories of persons. Then,we compute the signature and represent it based on the approach of Part Appearance Mixture (PAM). Anevaluation of the quality of this signature representation is also described in order to essentially solve the problemsof high variance in a person’s appearance, occlusions, illumination changes and person’s orientation/pose. Todeal with variance in a person’s appearance, we represent it as a set of multi-modal feature distributions modeledby Gaussian Mixture Model (GMM). Experiments and results on two public datasets and on our own datasetshow good performance